Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05278065 · ClinicalTrials.gov registry record · NA
E-cigarettes for Harm Reduction in Adults With Asthma
A NA study of Asthma and Smoking, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05278065: Completed NA study of Asthma and Smoking, sponsored by Brown University.
NCT05278065 is a NA study of Asthma and Smoking that has completed, run by Brown University. The registered enrollment target is 17 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05278065, a NA study of Asthma and Smoking, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Smoking is the main cause of preventable disease and death in the US and impacts respiratory illnesses including COPD and asthma. However, little is known about the effects on smoking and lung health of substituting cigarettes with ENDS in adults with asthma. This project aims to test whether providing ENDS to adults with asthma will lead to substitution of smoking for ENDS, reduced dependence, and improved lung function so such knowledge can inform interventions to reduce the public health burden of tobacco.
Primary Outcome
Past week average cigarettes per day assessed using timeline follow-back (TLFB).
Conditions Studied
Interventions
- OTHER Nicotine
Study Locations (1)
Rhode Island
- Center for Alcohol and Addiction Studies - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2024-09-12 |
| Phase | NA |
What the finished NCT05278065 record still lists
NCT05278065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Nicotine is the first listed.
NCT05278065 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05278065 about?
NCT05278065 is a clinical study titled "E-cigarettes for Harm Reduction in Adults With Asthma". Smoking is the main cause of preventable disease and death in the US and impacts respiratory illnesses including COPD and asthma. However, little is known about the effects on smoking and lung health of substituting cigarettes with ENDS in adults with asthma. This project aims to test whether provid...
What is the current status of trial NCT05278065?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2022-05-01. Estimated completion is 2024-09-12.
What conditions does trial NCT05278065 study?
This clinical trial studies the following conditions: Asthma, Smoking, Cigarette Smoking, Electronic Cigarette Use.
What interventions are being tested in trial NCT05278065?
The interventions under investigation include: Nicotine (OTHER).
Who is sponsoring clinical trial NCT05278065?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05278065 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05278065's enrollment target sits among peer trials
17 349th of 374 higher than 26 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI